Illustration: Victoria Ellis/Axios
InpharmD raised a $6.05 million seed to make on-demand drug information accessible, CEO Ashish Advani tells Axios exclusively.
Why it matters: Hospitals face pressing challenges accessing reliable drug information amid staffing problems and rising drug costs.